# MSN Laboratories Private Limited, Unit-II, Sangareddy District, India – FDA Inspections

Source: https://www.keypedia.com/companies/msn-laboratories-private-limited-unit-ii/539d7af5-94e6-4abe-b01b-fa911be84d2a

> Inspection records and compliance data for MSN Laboratories Private Limited, Unit-II in Sangareddy District, NA. 3 FDA inspections on record, last inspected March 22, 2024.

---

## Details

- Name: MSN Laboratories Private Limited, Unit-II
- FEI Number: 3008656542
- Business Operations: API MANUFACTURE
- Address Line 1: Patancheru
- City: Sangareddy District
- State: NA
- Zip Code: 50230
- Country Name: India
- Address: Patancheru, Sangareddy District, NA 50230, India
- Country: India

## Related Documents

- [483 - MSN Laboratories Private Limited, Unit-II - 2024-03-22](https://www.keypedia.com/records/483/msn-laboratories-private-limited-unit-ii/2086fcb4-ba6f-4b62-91be-759d5efa8f51) — source: FDA, date: March 22, 2024
- [FDA Inspection 1236036 - MSN Laboratories Private Limited, Unit-II - 2024-03-22](https://www.keypedia.com/records/fda_inspections/msn-laboratories-private-limited-unit-ii/3d84b80d-e48d-4c74-a537-2409078c643e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 22, 2024
- [EIR - MSN Laboratories Private Limited, Unit-II - 2018-05-25](https://www.keypedia.com/records/eir/msn-laboratories-private-limited-unit-ii/d98165d9-f691-4430-80c7-892984206a91) — source: FDA, date: May 25, 2018
- [FDA Inspection 1057811 - MSN Laboratories Private Limited, Unit-II - 2018-05-25](https://www.keypedia.com/records/fda_inspections/msn-laboratories-private-limited-unit-ii/a951698d-23d7-42d7-b227-5428f34ecf0a) — classification: No Action Indicated (NAI), source: FDA, date: May 25, 2018
- [FDA Inspection 922563 - MSN Laboratories Private Limited, Unit-II - 2015-04-03](https://www.keypedia.com/records/fda_inspections/msn-laboratories-private-limited-unit-ii/0a720dad-e274-43c2-a0f7-253195bf84dc) — classification: No Action Indicated (NAI), source: FDA, date: April 3, 2015

## Related Companies

- [Biocon Biosphere Limited](https://www.keypedia.com/companies/biocon-biosphere-limited/4c5f824e-c399-4c0e-91be-45739741dc2c)
- [Biocon Limited](https://www.keypedia.com/companies/biocon-limited/7b8920c7-f5be-4f17-8100-3bede3943790)
- [Agilent Technologies Inc](https://www.keypedia.com/companies/agilent-technologies-inc/865fe026-9db0-4e3e-bc4a-e0d25b465093)
- [Organo Sintesis, S.A. De C.V.](https://www.keypedia.com/companies/organo-sintesis-sa-de-cv/0d8f4d8d-0fbd-4c4a-8362-439c74e4f37d)
- [ImClone Systems, LLC](https://www.keypedia.com/companies/imclone-systems-llc/ccde4edf-e0cb-4367-a935-725ce0bad4d3)
- [Cipla Ltd.](https://www.keypedia.com/companies/cipla-ltd/d90a952b-3052-4e33-9969-5db3f2bbae82)
- [Ercros S.A.](https://www.keypedia.com/companies/ercros-sa/adeb63ee-2821-47de-939a-39c363e39854)
- [GlaxoSmithKline dba Human Genome Sciences Inc](https://www.keypedia.com/companies/glaxosmithkline-dba-human-genome-sciences-inc/c3dd2e54-125d-4d56-b0dc-18cb333074cc)
- [SpecGx LLC](https://www.keypedia.com/companies/specgx-llc/715bb75a-8d3a-4469-9e6d-f617c2f39c93)
- [QOL Medical LLC](https://www.keypedia.com/companies/qol-medical-llc/83e2d372-ec27-4388-ab26-9774d5edcc55)

## Related Officers

- [GDUFA Supervisory Investigator](https://www.keypedia.com/people/paul-c-mouris/0da88ac4-d475-412f-8505-5a43dc8aea41)
- [issuing_officer](https://www.keypedia.com/people/gam-s-zamil/75bc04d4-6013-43b5-8200-8b513c814a7c)
- [M.S., Consumer Safety Officer at FDA](https://www.keypedia.com/people/daniel-l-zheng/5e3d993f-654e-4d40-a2c8-69c5e396499f)
